Metabolic syndrome does not impact long-term survival in patients with acute myocardial infarction after successful percutaneous coronary intervention with drug-eluting stents

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 5, 2014, Pages 713-720

  Won, Ki Bum ^a   Kim, Byeong Keuk ^b   Chang, Hyuk Jae ^b   Shin, Dong Ho ^b   Kim, Jung Sun ^b   Ko, Young Guk ^b   Choi, Donghoon ^b   Ha, Jong Won ^b   Hong, Myeong Ki ^b   Jang, Yangsoo ^b  

^a Hanyang Medical Center   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

acute myocardial infarction; drug eluting stent; metabolic syndrome; survival

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY REPERFUSION; DRUG ELUTING STENT; FEMALE; HEART DEATH; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS;

ACUTE MYOCARDIAL INFARCTION; DRUG-ELUTING STENT; METABOLIC SYNDROME; SURVIVAL;

AGED; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899466165     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25150     Document Type: Article

References (33)

1. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, Lakatta EG,. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43: 1388-1395.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT, the metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
3. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N,. Prevalence of the metabolic syndrome in American adolescents: Findings from the third national health and nutrition examination survey. Circulation 2004; 110: 2494-2497.
4. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, Beer JC, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Vergès B, Cottin Y,. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165: 1192-1198.
5. Takeno M, Yasuda S, Otsuka Y, Morii I, Kawamura A, Yano K, Miyazaki S,. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: Potential association with C-reactive protein. Circ J 2008; 72: 415-419.
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
7. Apple FS, Wu AH, Jaffe AS,. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J 2002; 144: 981-986.
8. Gupta AK, Prieto-Merino D, Dahlöf B, Sever PS, Poulter NR,. Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14120 hypertensive patients of ASCOT-BPLA: Comparison of their relative predictability using a novel approach. Diabet Med 2011; 28: 941-947.
9. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS,. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42-46.
10. Nusca A, Melfi R, Patti G, Di Sciascio G,. Statin loading for acute coronary syndromes. Curr Opin Cardiol 2010; 25: 373-378.
11. Bavry AA, Mood GR, Kumbhani DJ, Borek PP, Askari AT, Bhatt DL,. Long-term benefi t of statin therapy initiated during hospitalization for an acute coronary syndrome: A systematic review of randomized trials. Am J Cardiovasc Drugs 2007; 7: 135-141.
12. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK,. Increasing prevalence of metabolic syndrome in Korea: The Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011; 34: 1323-1328.
13. Koehler C, Ott P, Benke I, Hanefeld M,. Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: The Diabetes in Germany (DIG) Study. Horm Metab Res 2007; 39: 632-635.
14. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS, the usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1206-1211.
15. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven G, Hama Sambo B, Mendis S, Roglic G, the metabolic syndrome: Useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010; 53: 600-605.
16. Won KB, Chang HJ, Kim HC, Jeon K, Lee H, Shin S, Cho IJ, Park SH, Lee SH, Jang Y,. Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes. Cardiovasc Diabetol 2013; 12: 41.
17. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr., Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097-1105.
18. Peeters A, Barendregt JJ, Wilekens F, Mackenbach JP, Al Mamun A, Bonneux L,. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med 2003; 138: 24-32.
19. Horwich TB, Fonaraow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH, the relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38: 789-795.
20. Morse SA, Gulati R, Reisin E, the obesity paradox and cardiovascular disease. Curr Hypertens Rep 2010; 12: 120-126.
21. Wienbergen H, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Gohlke H, Senges J,. Impact of body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clin Res Cardiol 2008; 97: 83-88.
22. Mehta RH, Califf RM, Garg J, White HD, Van de Werf F, Armstrong PW, Pieper KS, Topol EJ, Granger CB, the impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction. Eur Heart J 2007; 28: 415-424.
23. Iakobishvili Z, Danicek V, Porter A, Assali AR, Battler A, Hasdai D,. Is increased body mass index associated with a cardioprotective effect after ST-segment-elevation myocardial infarction? Acute Card Care 2006; 8: 95-98.
24. Bucholz EM, Rathore SS, Reid KJ, Jones PG, Chan PS, Rich MW, Spertus JA, Krumholz HM,. Body mass index and mortality in acute myocardial infarction patients. Am J Med 2012; 125: 796-803.
25. Lundergan CF, Ross AM, McCarthy WF, Reiner JS, Boyle D, Fink C, Califf RM, Topol EJ, Simoons ML, Van Den Brand M, Van de Werf F, Coyne KS,. Predictors of left ventricular function after acute myocardial infarction: Effects of time to treatment, patency, and body mass index. Am Heart J 2001; 142: 43-50.
26. Habbu A, Lakkis NM, Dokainish H, the obesity paradox: Fact or fiction? Am J Cardiol 2006; 98: 944-948.
27. Knudtson MD, Klein BE, Klein R, Shankar A,. Association with weight loss and subsequent mortality risk. Ann Epidemiol 2005; 15: 483-491.
28. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR,. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565.
29. Ridker PM,. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
30. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J,. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study. Circulation 2003; 108: 414-419.
31. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW,. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 2004; 110: 380-385.
32. Hwang MJ, Chung WS, Gallagher D, Kim DY, Shin HD, Song MY,. How useful is waist circumference for assessment of abdominal obesity in Korean pre-menopausal women during weight loss? Asia Pac J Clin Nutr 2008; 17: 229-234.
33. King SB III, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, Feldman TE, Kern MJ, O'Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW,. 2007 focused update of theACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 2008; 51: 172-209.